Perineural Invasion in Adenoid Cystic Carcinoma of the Salivary Glands: Where We Are and Where We Need to Go

被引:37
|
作者
Liu, Xiaohao [1 ]
Yang, Xiaojun [1 ]
Zhan, Chaoning [1 ]
Zhang, Yan [1 ]
Hou, Jin [1 ]
Yin, Xuemin [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Oral & Maxillofacial Surg, Guangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
adenoid cystic carcinoma; salivary glands; perineural invasion; tumor microenvironment; perineurium barrier; TIGHT JUNCTION PROTEINS; NERVE GROWTH-FACTOR; PANCREATIC-CANCER; EXTRACELLULAR VESICLES; NECK-CANCER; NEUROTROPHIC FACTOR; PROGNOSTIC-FACTORS; SURGICAL MARGINS; POOR-PROGNOSIS; STELLATE CELLS;
D O I
10.3389/fonc.2020.01493
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adenoid cystic carcinoma of the salivary gland (SACC) is a rare malignant tumors of the head and neck region, but it is one of the most common malignant tumors that are prone to perineural invasion (PNI) of the head and neck. The prognosis of patients with SACC is strongly associated with the presence of perineural spread (PNS). Although many contributing factors have been reported, the mechanisms underlying the preferential destruction of the blood-nerve barrier (BNB) by tumors and the infiltration of the tumor microenvironment by nerve fibers in SACC, have received little research attention. This review summarizes the current knowledge concerning the characteristics of SACC in relation to the PNI, and then highlights the interplay between components of the tumor microenvironment and perineural niche, as well as their contributions to the PNI. Finally, we provide new insights into the possible mechanisms underlying the pathogenesis of PNI, with particular emphasis on the role of extracellular vesicles that may serve as an attractive entry point in future studies.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Research on Multiple Chronic Conditions Where We Are and Where We Need to Go
    Tinetti, Mary E.
    Basu, Jayasree
    MEDICAL CARE, 2014, 52 (03) : S3 - S6
  • [42] The oropharyngeal delivery of interferons: Where are we and where do we need to go?
    Bocci, V
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (08): : 859 - 861
  • [43] Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
    Ottenhoff, Tom H. M.
    Kaufmann, Stefan H. E.
    PLOS PATHOGENS, 2012, 8 (05)
  • [44] A half century later: Where are we? Where do we need to go?
    Barraga, NC
    JOURNAL OF VISUAL IMPAIRMENT & BLINDNESS, 2004, 98 (10) : 581 - 583
  • [45] Syndesmotic Injuries: Where Are We Now? Where Do We Need To Go?
    Mediouni, Mohamed
    Schlatterer, Daniel R.
    Gardner, Michael
    JOURNAL OF FOOT & ANKLE SURGERY, 2017, 56 (05): : 1129 - 1129
  • [46] Advancing womanist identity development: Where we are and where we need to go
    Moradi, B
    COUNSELING PSYCHOLOGIST, 2005, 33 (02): : 225 - 253
  • [47] High-frequency oscillations - Where we are and where we need to go
    Engel, Jerome, Jr.
    da Silva, Fernando Lopes
    PROGRESS IN NEUROBIOLOGY, 2012, 98 (03) : 316 - 318
  • [48] Restorative care in nursing homes: Where we are and where we need to go
    Resnick, B
    Remsburg, R
    Zimmerman, S
    Gruber-Baldini, A
    Berkovitz, A
    GERONTOLOGIST, 2004, 44 : 287 - 287
  • [49] Oncology nursing certification: Where we are and where we need to go.
    Brown, Carlton
    Nicholson, Lori
    Ponto, Julie
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 526 - 527
  • [50] Teachers and science curriculum materials: where we are and where we need to go
    Davis, Elizabeth A.
    Janssen, Fred J. J. M.
    Van Driel, Jan H.
    STUDIES IN SCIENCE EDUCATION, 2016, 52 (02) : 127 - 160